A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Public ClinicalTrials.gov record NCT07282613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes
Study identification
- NCT ID
- NCT07282613
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- CagriSema (Cagrilintide B and Semaglutide I) Drug
- Placebo matched to CagriSema (Cagrilintide B and Semaglutide I) Drug
Drug
Eligibility (public fields only)
- Age range
- 10 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 3, 2026
- Primary completion
- Sep 6, 2029
- Completion
- Mar 29, 2030
- Last update posted
- Mar 29, 2026
2026 – 2030
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale School of Medicine | New Haven | Connecticut | 06511 | — |
| Encore Medical Research Boynton Beach | Boynton Beach | Florida | 33436 | — |
| Nemours Chld Clnc Jacksonville | Jacksonville | Florida | 32207 | — |
| Innovus Clinical | Kissimmee | Florida | 34741 | — |
| D&H National Research Centers | Tamarac | Florida | 33321 | — |
| Clinical Research Trials of Florida | Tampa | Florida | 33607 | — |
| Columbus Research Foundation | Columbus | Georgia | 31904 | — |
| Eastside Bariatric and Gen Surg | Snellville | Georgia | 30078 | — |
| SIU Medicine | Springfield | Illinois | 62702 | — |
| Riley Hospital For Children | Indianapolis | Indiana | 46202 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Great Lakes Research Inst. | Southfield | Michigan | 48075 | — |
| UBMD Pediatrics | Buffalo | New York | 14203 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Children's Hosptl Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Monument Health Clinical Rsrch | Rapid City | South Dakota | 57701 | — |
| LifeDoc Health | Memphis | Tennessee | 38115 | — |
| Amir Ali Hassan, MD, PA | Houston | Texas | 77089 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
| UVA Health Systems | Charlottesville | Virginia | 22903 | — |
| Seattle Children's Research Institute | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07282613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07282613 live on ClinicalTrials.gov.